Donepezil SR 23 mg Tablets BE study [Study Per­for­mance]

posted by madhavaraob – 2010-07-07 09:27 (5828 d 10:21 ago) – Posting: # 5597
Views: 14,900

Dear all,

We are planning to conduct a bioequivalence study on Donepezil SR 23 mg tablets in comparision with 10 mg IR tablets for US regulatory. We would like to know whether this study is feasible to be conducted in healthy population or in patients?
If the study need to be conducted in patients, what is the severity of the diseased condition (mild/moderate/severe) to be selected?

With Regards,

Madhav

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
135 visitors (0 registered, 135 guests [including 41 identified bots]).
Forum time: 19:48 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5